financing

News

#InvestinBiotech yearly honeycomb on green background

UK biotech investment "holding firm", says BIA

The UK life sciences raised £1.23bn in venture capital investment in the first half of 2025, although there was a fallback in the second quarter.

News

Daniel Nadler, co-founder and chief executive of OpenEvidence

Medical chatbot firm OpenEvidence raises $210m

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.

News

New radiopharma Actithera emerges with $75.5m in financing

A new player in radioligand therapies, Actithera, has arrived on the scene with $75.5m in funding and lead FAP-targeted candidate for cancer.

News

Amid sector disruption, biotech must focus on 'fundamentals'...

The biotech industry in the US is facing a period of deep uncertainty under the Trump administration, but can ride out the storm, says EY.

News

rofessor John Atack and Professor Simon Ward, from Cardiff University’s Medicines Discovery Institute

Welsh biotech Draig emerges with $140m in financing

Draig Therapeutics emerged from the shadows this morning with $140m in funding and a quest to develop new therapies for neuropsychiatric diseases.

News

Caris swells its planned IPO, seeking $5.7bn valuation

AI-powered techbio firm Caris Life Sciences has raised the target price for its IPO, pointing to strong demand among investors.

UK biotech investment "holding firm", says BIA

Medical chatbot firm OpenEvidence raises $210m

New radiopharma Actithera emerges with $75.5m in financing

Amid sector disruption, biotech must focus on 'fundamentals'...

Welsh biotech Draig emerges with $140m in financing

Caris swells its planned IPO, seeking $5.7bn valuation

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

financing

Editor's Picks